19 Oct 2017 | 6:40 AM
Research Report
Daily

Equity Research Report: Religare Morning Digest

Participants should maintain caution approach in early trades on Monday as markets would react to the IIP numbers. We expect a strong directional move on upside if Nifty sustains above 7850 spot level else consolidation will continue.
14 Sep 2015 | 07:00 AM

    Highlights for Today
 
Market Outlook for the day -Participants should maintain caution approach in early trades on Monday as markets would react to the IIP numbers. We expect a strong directional move on upside if Nifty sustains above 7850 spot level else consolidation will continue.
Key Indices – Levels to watch out for the day
INDEX (Spot) RESISTANCE 2 RESISTANCE 1 LTP SUPPORT 1 SUPPORT 2
SENSEX 26050 25860 25610.21 25420 25250
NIFTY 7950 7850 7789.30 7720 7660
BANKNIFTY 17000 16820 16612.60 16420 16200
CNX-IT 11640 11525 11432.25 11250 11090
News -
  • Arvind Ltd announced its entry into beauty and cosmetics segment through a partnership with Sephora, a part of French Luxury major, LVMH Moet Hennessy Louis Vuitton.
  • Andhra Bank plans to raise Rs. 700 crore through qualified institutional placement (QIP) next quarter.
  • Sun Pharmaceutical Industries clarified with regard to media reports on divestment of Ireland plant said that the Ireland facility has been identified by the firm for divestment.
 
    Trading/ Investment Ideas
Technical Calls
Company
Name
Recommendation CMP Initiation
Range
Stop
loss
Target Time
Frame
BRITANNIA BUY 2953.85 2920 - 2930 2850 3100 3-5 Days
BPCL BUY 850.55 846 - 848 825 900 3-5 Days
 
Derivatives Call
Company
Name
Recommendation CMP Initiation
Price
Stop
loss
Target Time
Frame
PIDILITIND BUY FUTS 568.90 565 555 585 3-5 Days
 
Master Pick (1-2 Months)
Company
Name
Recommendation CMP Initiation
Range
Stop
loss
Target
DISHTV BUY 104.20 100-105 94 130
To read complete report, please click here
 
Fundamental Picks for delivery ( 9 Months - 1 Year)
Company
Name
Recommendation CMP Initiation
Range
Target
KOTAKBANK BUY 631.25 705.10 900
Note – For our running recommendations and past performance, please click here
Research Disclaimer